Objectives-To analyse synovial fluid and serum concentrations of the aminopropeptide of the type M procoliagen
a weak positive correlation between synovial fluid leucocyte counts, some radiographic changes, and synovial fluid PIIINP concentrations. Conclusions-These data suggest that synovial fluid PIIINP concentrations may reflect local synovial proliferative processes in joint disease, and that they could be of diagnostic and prognostic value in inflammatory arthropathies. The normal synovial membrane is composed of synovial cells supported by a loose fibrillar network, consisting primarily of a mixture of fibres derived from types I and III collagens. '-3 In joint diseases the membrane becomes inflamed. However, the degree of inflammation (synovitis) varies, and is much greater in some conditions (for example rheumatoid arthritis (RA) and psoriatic arthritis (PsA)) than in others (for example osteoarthritis (OA)). Moreover, the nature of synovial response may vary with differing degrees of synovial proliferation. In RA, this proliferative response is more marked than in other disorders of the joints and is associated with an enhanced synthesis and deposition of type III collagen in the rheumatoid synovial tissue. 4 Type III collagen is primarily synthesised during growth and development, wound healing and inflammation, and is one of the main fibrillar collagens present in the synovium. Type III collagen is synthesised as a procollagen molecule with non-collagenous aminopropeptide (PIIINP) and carboxypropeptide (PIIICP) extensions that are secreted into the extracellular space and can be measured in both serum and synovial fluid. Both PIIINP and PIIICP concentrations therefore reflect the rate of type III collagen synthesis. 5 Serum concentrations of PIIINP have been studied widely;`9 they are believed to provide prognostic information6' in RA, and may provide some information on disease activity in scleroderma. Synovial fluid concentrations are much less studied, but may reflect local production by proliferating synovium. products.9 All serum and synovial fluid samples were assayed in duplicate, either undiluted (serum) or diluted 1:10 (SF). The intra-and interassay variations of the assays for serum were 5% and 8%, respectively, and those for synovial fluid were 6% and 13%, respectively.
STATISTICAL METHODS
Linear regression analysis was used to test for association between PIIINP concentrations, age, and disease duration. Comparisons were made using one way analysis of variance. To test for between group differences in the concentrations of PIIINP, post hoc pairwise comparisons were made using Tukey's simultaneous confidence intervals. The association between serum and synovial fluid PIIINP concentrations and radiographic features were tested, having allowed for disease group, using two way analysis of variance; correlations were calculated using the Spearman correlation coefficient. Statistical significance was set at the 5% level.
Results Table 1 shows the demographic data of all the subjects in the study. The groups were not matched for age or gender, and there were significant differences in mean age, gender, and disease duration of the patients in all three disease groups. Table 2 shows the serum concentrations of PIIINP. All three disease groups had greater serum PIIINP concentrations than the normal controls (p < 0-001 for OA and RA; p = 0 079 for PsA), but there were no significant differences between the disease groups. Regression analysis (allowing for disease groups) showed no association between serum concentrations of PIIINP and age (p = 0925), gender (p = 0A430) or disease duration (p = 0 990).
The volume of synovial fluid aspirated did not affect the concentrations of PIIINP (fig 1) . The mean synovial fluid concentrations of PIIINP were much greater than those in serum in all groups, including the normal subjects (table 2) . There were no significant correlations between the serum and synovial fluid PIIINP concentrations (r = 0-246), p = 0-063, n = 58). Calculation of the median synovial fluid:serum PIIINP ratios for the paired samples showed that the ratios were in the order: normal controls <OA <PsA <RA (table 2). Figure 2 shows the individual synovial fluid PIIINP concentrations in each group. Synovial fluid concentrations were greatly increased (p < 0-001) in all three disease groups compared with the normal To examine if the synovial fluid total leucocyte count reflected local inflammation in joint diseases and was associated with locally produced PIIINP, the leucocyte counts of the different groups were compared with each other and with synovial fluid PIIINP concentrations. The counts were greater in all the disease groups compared with the normal controls (table 3) and, as expected, the inflammatory groups had greater leucocyte counts than the non-inflammatory group. The leucocyte counts in OA synovial fluid were estimates rather than accurate counts and therefore were not used in any calculations. When the counts of the remaining groups were put together and correlated with synovial fluid PIIINP concentrations, a weak positive correlation (r= 0-453, p < 0-001) was found. After allowing for disease group, this correlation was no longer significant (r = -0 148, p = 0 089).
To test for any possible associations between joint damage and PIIINP concentrations, various radiographic features of the knee joint were related to the concentrations of PIIINP measured in the synovial fluids from the same joint in addition to those in serum. As the distribution of PIIINP concentrations was found to be highly skewed (non-normal distribution), logarithmically transformed (natural log or Ln) data were used for analysis, but no significant association was found between serum PIIINP and any of the radiographic features. Table 4 The highly significant difference (p < 0001) between RA and PsA may reflect increased fibroblastic activity in RA, contribution from other tissues within the RA joint, or both.
The differences in the serum and synovial fluid concentrations of PIIINP between the normal controls and the arthritic groups, or between the arthritic groups themselves, could have resulted partly from background variables such as age, gender and disease duration: indeed, synovial fluid PIIINP was found to be positively associated with age. However, we were able to account for such variables using the linear regression model. Also Several earlier reports associated serum PIIINP concentrations with disease progression in RA.6 50 As the synovial fluid concentrations of PIIINP is highly increased in RA, while the serum concentration was found to be similar to that in the other arthritic groups in this study, the synovial fluid concentrations of PIIINP might be of even greater prognostic value than serum concentrations, for an individual RA joint. Moreover, the highly significant increase in synovial fluid PIIINP concentrations in RA compared with PsA suggests that the synovial response is different in the two disorders. In early seronegative arthritis, it may be difficult to differentiate seronegative spondarthritides from early RA, in which most of the conventional serum or synovial fluid assays are often non-discriminatory. Synovial fluid PIIINP concentrations may provide a helpful diagnostic marker in these conditions, but these results require confirmation in a study of larger numbers of patients, and the potential prognostic value of synovial fluid PIIINP concentrations requires investigation in a prospective study. 
